EcoNugenics® Wins the 2004 Nutrition Business Journal Product Merit Award for PectaSol® Modified Citrus Pectin
Good news in the nutraceutical industry. EcoNugenics received the 2004 Nutrition Business Journal Product Merit Award for PectaSol® MCP. Studies have demonstrated its impact on inhibiting cancer metastasis and reducing tumor growth. It has been particularly effective in the treatment of prostate cancer. PectaSol® is more readily absorbed into the bloodstream than other pectin due to its structure and molecular weight.
Santa Rosa, CA (PRWEB) March 10, 2005 -- EcoNugenics,® a premium dietary
supplement and nutraceutical company, announced today that they have received
the 2004 Nutrition Business Journal Product Merit Award for PectaSol,® Modified
Citrus Pectin, a dietary supplement derived from the peel and pulp of citrus
fruit. The dietary supplement is recognized for its interaction with cellular
adhesion.
“EcoNugenics® is honored to receive this Product Merit Award
from The Nutrition Business Journal,” said Isaac Eliaz, MD, a leader in the
field of Integrative Medicine. “The strategic information about PectaSol® is
that studies have demonstrated its effect on inhibiting cancer metastasis and
reducing tumor growth. In prostate cancer, PectaSol® has been clinically shown
to considerably slow the prostate specific antigen, PSA doubling
time.”
The molecular weight and proper structure of the citrus pectin
used in PectaSol® have been modified through several proprietary laboratory
processes, making PectaSol® more readily absorbed into the bloodstream than
regular pectin. PectaSol’s unique component, galactyosyl, has an affinity for
binding to certain cells of the prostate, breast, colon, lymphatic system, skin,
brain and larynx. For more information and to view clinical research on
PectaSol® visit www.econugenics.com.
EcoNugenics® was founded in 1995
with a commitment to offering premium dietary supplements and nutraceuticals
based on the best of modern science integrated with the ancient wisdom of
traditional and complementary therapies. EcoNugenics® is committed to five basic
principles, which include innovation in product formulation, thorough scientific
research, ongoing clinical validation, customer education/empowerment and
superior quality control.
For more information contact Connie St. John
at 415-454-2243.
# # #
Source : http://www.prweb.com/releases/2005/3/prweb216416.htm